Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.100 |
None |
1.000 |
51 |
|
1998 |
2019 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.100 |
None |
1.000 |
32 |
|
1998 |
2019 |
Sarcoma, Epithelioid
|
disease |
Neoplasms
|
Neoplastic Process
|
66
|
|
0.100 |
None |
0.967 |
30 |
|
2005 |
2019 |
Childhood Atypical Teratoid/Rhabdoid Tumor
|
disease |
|
Neoplastic Process
|
28
|
|
0.100 |
None |
0.897 |
29 |
|
2003 |
2019 |
Childhood Epithelioid Sarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
33
|
|
0.100 |
None |
0.957 |
23 |
|
2005 |
2019 |
Carcinoma
|
group |
Neoplasms
|
Neoplastic Process
|
2462
|
103
|
0.100 |
None |
0.913 |
23 |
|
1999 |
2020 |
Adult Epithelioid Sarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
33
|
|
0.100 |
None |
0.957 |
23 |
|
2005 |
2019 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.100 |
None |
0.952 |
21 |
|
1998 |
2019 |
Malaria
|
disease |
Infections
|
Disease or Syndrome
|
685
|
148
|
0.100 |
None |
0.812 |
16 |
|
2014 |
2019 |
Familial (FPAH)
|
disease |
|
Disease or Syndrome
|
1075
|
276
|
0.100 |
None |
1.000 |
15 |
|
2005 |
2018 |
Neurofibromatosis 2
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Nervous System Diseases; Otorhinolaryngologic Diseases
|
Neoplastic Process
|
127
|
49
|
0.100 |
None |
0.857 |
14 |
|
2001 |
2019 |
Brain Neoplasms
|
group |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
1018
|
204
|
0.100 |
None |
1.000 |
13 |
|
2000 |
2019 |
Sarcoma
|
group |
Neoplasms
|
Neoplastic Process
|
853
|
42
|
0.100 |
None |
1.000 |
12 |
|
2005 |
2019 |
Chordoma
|
disease |
Neoplasms
|
Neoplastic Process
|
140
|
3
|
0.100 |
None |
1.000 |
12 |
|
2010 |
2020 |
Renal medullary carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
12
|
|
0.100 |
None |
1.000 |
10 |
|
2012 |
2019 |
Multiple congenital anomalies
|
group |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
|
Congenital Abnormality
|
251
|
350
|
0.100 |
None |
1.000 |
5 |
1
|
2012 |
2014 |
Dysmorphic features
|
disease |
|
Congenital Abnormality
|
439
|
617
|
0.100 |
None |
1.000 |
5 |
1
|
2012 |
2014 |
Muscle hypotonia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Finding
|
967
|
579
|
0.100 |
None |
1.000 |
5 |
2
|
2012 |
2014 |
Neoplastic Syndromes, Hereditary
|
group |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms
|
Neoplastic Process
|
88
|
6387
|
0.100 |
None |
1.000 |
1 |
1
|
2010 |
2010 |
Fractional shortening
|
phenotype |
|
Finding
|
4
|
4
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Neoplasm of the anterior pituitary
|
disease |
Neoplasms; Nervous System Diseases; Endocrine System Diseases
|
Neoplastic Process
|
6
|
|
0.100 |
None |
|
0 |
|
|
|
Blindness
|
phenotype |
Pathological Conditions, Signs and Symptoms; Eye Diseases; Nervous System Diseases
|
Disease or Syndrome
|
393
|
34
|
0.100 |
None |
|
0 |
|
|
|
Decreased circulating ACTH level
|
phenotype |
|
Finding
|
18
|
|
0.100 |
None |
|
0 |
|
|
|
Abnormality of cardiovascular system morphology
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Cardiovascular Diseases
|
Congenital Abnormality
|
198
|
13
|
0.100 |
None |
|
0 |
|
|
|
Decreased circulating follicle stimulating hormone level
|
phenotype |
|
Finding
|
5
|
|
0.100 |
None |
|
0 |
|
|
|